https://www.clinicaltrialsarena.com/news/evaxion-trial-melanoma-vaccine/
Evaxion Biotech has completed subject dosing in the Phase II trial of EVX-01, for the treatment of advanced melanoma.
phase ii trialmelanoma vaccineconcludesdosing
https://www.finanzen.net/nachricht/aktien/moderna-merck-cancer-vaccine-shows-durable-benefit-at-5-years-in-high-risk-melanoma-15425603
Moderna-Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma | finanzen.net
cancer vaccinemodernamerckshowsdurable
https://www.sciencetimes.com/articles/41360/20221213/moderna-merck-to-make-vaccine-for-melanoma-skin-cancer.htm
Moderna and Merck's COVID-19-based skin cancer vaccine performed effectively in a mid-stage research. Read on to know more about the details.
melanoma skin cancermodernamerckmakevaccine
https://www.ajmc.com/view/small-study-confirms-feasibility-of-a-personalized-neoantigen-vaccine-for-melanoma
A new study, published in the journal Nature, has confirmed the efficacy of a melanoma vaccine targeted against 20 predicted personal tumor neoantigens in 6...
small studyconfirmsfeasibilitypersonalizedneoantigen
https://www.clinicaltrialsarena.com/news/moderna-cancer-vaccine-intismeran-autogene-keytruda-melanoma-phase-iib/
Moderna's cancer vaccine, intismeran autogene plus Keytruda significantly prolonged recurrence-free survival (RFS) in patients with high-risk melanoma after...
cancer vaccinemodernamsdpluskeytruda
https://www.sciencedaily.com/releases/2009/06/090601092239.htm
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined...
vaccineshowstherapeuticpromiseadvanced